The present case reports describe a young male and a young female patient diagnosed with generalized non-small cell lung adenocarcinoma with brain metastases and ALK translocation. Brain metastases are detected in 30% of patients with ALK-positive NSCLC at the time of cancer diagnosis.
The discussion section deals with the intracranial efficacy of individual ALK inhibitors.